Inhibition of a mitochondrial protein, a new therapeutic target for cholestatic liver diseases

by CIC bioGUNE

​The presence of this protein slows down the activity of the mitochondria, decreasing their ability to eliminate toxic substances such as certain bile acids.

Read more

Versantis raises CHF 4,4 million in series a financing to advance new generation of liver disease medicines

by Healthequity

Versantis, a pharmaceutical company focused on the development of products addressing a high unmet medical need in the diagnosis, prevention, and treatment of liver diseases, today announces the closi...

Read more

OWL Metabolomics in the front row of NASH and NAFLD non-invasive diagnosis

by CRB Inverbío SA SGECR

One Way Liver S.L. (OWL Metabolomics), a leader in the field of metabolomics focused on development of innovative diagnostic tests for common liver diseases, strengthens its position in NASH and NAFLD...

Read more

Galmed Pharmaceuticals to hold a symposium on non-invasive diagnostics during the International Liver Congress in Spain

by CRB Inverbío SA SGECR

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of a once-daily, oral therapy for the treatment of liver d...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

UPF and Hospital del Mar design a method...

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The new method would allow for a more objective and precise classifica...

Photos Stream